Safety of Brodalumab for Plaque Psoriasis Treatment
In research presented at the 2023 SDPA summer conference, new pharmacovigilance data over a 4-year span aligned with the established safety profile on brodalumab.
Source: hcplive.com
Stay updated with breaking news from Jacobsona Brodalumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In research presented at the 2023 SDPA summer conference, new pharmacovigilance data over a 4-year span aligned with the established safety profile on brodalumab.